Kai-Chien Yang

14PUBLICATIONS
60CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Aerodynamics (excl. hypersonic aerodynamics)Medical devicesCellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 05, 2026
Targeting fibroblast TXNDC5 resolves tumor desmoplasia and PD-1 resistance in colorectal cancer with mesenchymal traits.

|May 04, 2026
Combined Curcumin and Doxorubicin Induce Apoptosis via JNK-Dependent MAPK Signaling Independent of TXNDC5 in Human Osteosarcoma Cells.

|Apr 14, 2026
Cell-Specific Roles of Angiopoietin-2 in CKD.

An-Jie Luo, Tyng-Shiuan Gau, Ming-Tsun Tsai

|Jan 23, 2026
Precision mRNA Nanomedicine for Targeted Vascular Therapies in ARDS and Atherosclerosis.

Zhengjie Zhou, Jiayu Zhu, Chih-Fan Yeh

|Jan 21, 2025
N-Cadherin promotes cardiac regeneration by potentiating pro-mitotic β-Catenin signaling in cardiomyocytes.

Yi-Wei Tsai, Yi-Shuan Tseng, Yu-Shuo Wu

|Sep 14, 2024
Parecoxib Enhances Resveratrol against Human Colorectal Cancer Cells through Akt and TXNDC5 Inhibition and MAPK Regulation.

Wan-Ling Chang, Kai-Chien Yang, Jyun-Yu Peng

Pageof 3

Frequent Collaborators

3 joint publications

Sung-Jan Lin

3 joint publications

Chih-Fan Yeh

2 joint publications

Yi-Wei Tsai

2 joint publications

Ru-Ting Huang